- CEL-SCI (NYSE:CVM) announced that it intends to offer to sell shares of its common stock in a best efforts public offering.
- The company intends to use the net proceeds from this offering to fund the continued development of Multikine, for general corporate purposes, and working capital.
- CVM +4.64% after hours to $0.628.
- Source: Press Release